Supporting the aforementioned hypothesis, recent studies have shown that the dysregulation of ARHGAP35 expression and function is involved in the tumorigenesis of some tumors such as lung cancer [30], melanoma [31], and breast cancer [19, 28, 32]. This evidence concerns the gene ARHGAP35 and lung carcinoma.